Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Tuesday, June 30

POSER SESIOS Trc B 227220

22277 Topical 9-cis-Retinoic acid (PanretinT) gel as treatment of cutaneous
AIDS-related Kaposi's sarcoma: Interim results of an international,
placebo-controlled trial (ALRT 1057-503)
Neil Bodsworth*; On Behalf of the International Panretin KS Study Group
Intern, Australia
22278 Phase 2 study (protocol L1057-28) of PanretinT gel capsules (LGD1057,
ALRT1057) for AIDS-related Kaposi's Sarcoma
Alvin Friedman-Kien*; M. Conant, USA
22279 Antitumor activity of Interleukin-4 toxin in nude mice implanted with
AIDS-associated Kaposi's sarcoma tumor
Syed R. Husain l*; R.J. Kreitman2; I. Pastan2; R.K. Puri3, USA
22280 A phase II study of oral thalidomide in patients with AIDS-related
Kaposi's sarcoma (KS)
Robert Yarchoan*; Richard F. Little; K. Wyvill; L. Welles; J.M. Pluda;
W. Figg; G. Tosato, USA
22281 A phase I dose escalation study of 2'-1 -flouro-2',3'-dideoxyadenosine
(F-DDA, lodenosine) in patients with symptomatic HIV-infection
Robert Yarchoan*; Richard Little*;J.A. Lietzau; L. Welles;J.M. Pluda;
J.A. Kelley; H. Mitsuya; R. Yarchoan, USA
22282 HHV-8, proliferation, apoptosis and ploidy in epidemic (AKS), endemic
(EKS),and classical (CKS) Kaposi's sarcoma (KS)
Epahata Kaaya*; Peter Biberfeld; E. Castanous-Velez; T Heden; M. Stuzl; J.Z.
Zou; J.N. Kitinya, Sweden
22283 North American phase 3 study (protocol L1057T-31) of panretinT gel
(LGD1057,ALRT1057) for cutaneous AIDS-related Kaposi's sarcoma
Alvin Frie Dman-Kien*; M. Conant, USA
22284 Genetic abnormalities in Kaposi's sarcoma tumors
Charles Rabkin*; S. Janz; S. Pack; A. Coleman; E. Musaba; R. Biggar;
Z. Zhuang, USA
22285 Production of human 3 chemokines in AIDS-Kaposi's sarcoma patients
Maria Caterina Sirianni*; E. Scala; L. Vincenzi; S. Topino; M. Capuano;
F. Aiuti; B. Ensoli, Italy
22286 Kaposi's sarcoma: A new approach to follow-up using epiluminescent
light microscopy
Marl Delhere*; Joachim Krischer; T.L. Trellu Laurence; Sonia Roten;
Jean-Hilaine Saurat; Bernard Hirschel, Switzerland
22287 Kaposi's Sarcoma in AIDS Mexican patients
Carlos Lopez Martinez*; C. Magiz-Rodriguez; P. Uribe-Ziinga, Mexico
22288 Regression of AIDS-related Kaposi's sarcoma following combined
antiretroviral treatment
Alejandra Monticelli*; D.S. Lewi; H. Salomon; S. Pampuro; V. Hodara;
0. Libonatti; H. Jauregui Rueda, Argentina
22289 Concomitant CHOP chemotherapy (CT) and highly active antiretroviral
therapy (HAART) in patients (PTS) with HIV related non-Hodgkin's
lymphoma (HIV-NHL)
Emanuela Vaccner*; M. Spina; S. Santarossa; A. Lucenti; S. Jusbasic;
M. Tavio; U. Tirelli, Italy
22290 The emergence of AIDS-associated lymphoma is preceded by the overexpression of molecules associated with B cell activation
Otoniel Martinez-Maza*; Elizabeth Breen; D. Widney; R. Detels;
W. Cumberland; O. Martinez-Maza, USA

22291 Predictive Value of Thallium-201 Spect in the Diagnosis of Primary
Central Nervous System Lymphoma (PCNSL) in AIDS Patients
Felipe Garcia Alcaide*; F. Lomena; A. Cruceta; G. Rivera;J.M. Miro;
F. Gravs;J.M. Gatell, Spain
22292 AIDS malignancy bank: A source for tissue and biological fluids of HIV
related malignancies
John Flickinger*; S. Silver; J. Orenstein; S. Miles; C. Axiotis; L. Ayers;
M. McGrath, USA
22293 Complete remission of an high grade lymphoma obtained with HAART
and with Interleukine 2 after relapse. Role of the immune reconstitution
in therapy for HIV-lymphomas?
Francois Boue*; P. Miailmes; R. Fior; F. Carron; J. Maral; P. Galanaud,
France
22294 Idarubicin contained regimen in AIDS-Related non-Hodgkin's
lymphoma patients (AIDS-NHL Pts). Pilot study
Roberta Gastaldi*; Martino Pietro; Maurizio Martelli; Giuseppe Gentile;
lole Cordone; Arturo Cafolla; Franco Mandelli, Italy
22295 Risk factors for AIDS associated non-Hodgkin's lymphoma (NHL)
Andrew Grulich*; X. Wan; M. Law; S. Milliken; J. Gold; R. Finlayson;
J.M. Kaldor, Australia
22296 Infectious complications in patients with HIV related lymphoma
Tony Cheung*;S. Jones; F. Wallach, USA
22297 Second-line chemotherapy (CT) with CDE (cyclophosphamide,
doxorubicin, etoposide) in patients (pts) with resistant human
immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NHL)
Domenico Errante*; E. Vaccher; M. Tavio; G. Nasti; S. Sandri; 0. Schioppa;
U. Tirelli, Italy
22298 NHL-17 years follow up in a greek cohort of 158 (HIV+) haemophilia
patients
Anastasia Karafoulidou; Olga Katsarou*; E. Patsouris; Nikolaos
Moschopoulos; G. Touloumi; V. Kapsimali; S. Tsourakakis;
C. Panagiotopoulou; T. Mandalaki, Greece
22299 Primary central nervous system lymphoma with negative spect in a
patient with AIDS
Marcelo Corti* K. Corbera; N. Trione; M. Villafane; R. Schtirbu; C. Vivas;
R. Masini, Argentina
22300 Malignancies in children with HIV-infection
Mariana Mardarescu*; M. Luminos; S. Petrea; I. Darasteanu, Romania
NOTES

IUN

CONFERENCE WORKBOOK

89